Quantcast

Latest Cancer Research Stories

2014-03-17 08:29:07

HOUSTON, March 17, 2014 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers. "Our collaboration with MedImmune, a leader in the field of immunotherapy, will draw on the strengths of both institutions to push ahead for more effective...

2014-03-14 23:25:33

“Patients and their families will now have an easy access to the first American Hospice and Palliative Care Hospital and its extraordinary staff with caring hearts and spirits”, said Wen-Jen Hwu, M.D., Ph.D., Board of Directors and Chairman of Professional Advisory Committee, The University of Texax MD Anderson Cancer Center, Professor, Department of Melanoma Medical Oncology and United States Chairman of Woman in Cancer Research. New Haven, Connecticut (PRWEB) March 14, 2014 The...

2014-03-14 23:25:10

NOVA nominates Rebecca Kamen, Professor of Art, for Professor Emeritus to celebrate 35 years of distinguished service. Kamen's work is recognized for embodying the STEM to STEAM movement, and her approach is celebrated in both the art and scientific communities. McLean, VA (PRWEB) March 14, 2014 Northern Virginia Community College ( NOVA) recently nominated Rebecca Kamen, Professor of Art, for Professor Emeritus to celebrate 35 years of distinguished service, teaching excellence and...

2014-03-13 23:03:24

FDNA will unveil Face2Gene™, a mobile app for research and investigation of genetic syndromes, using facial photos. (PRWEB) March 13, 2014 FDNA® (http://www.fdna.com) – a pioneer in computer-aided dysmorphology analysis is scheduled to exhibit at the 2014 ACMG meeting, booth #915 in Nashville, Tennessee. The company will present its proprietary technology in a scheduled theater presentation and unveil Face2Gene, the first available search and reference mobile application, powered...

2014-03-10 08:30:35

BERGEN, Norway, March 10, 2014 /PRNewswire/ -- NOK 13 million funding secured from the Research Council of Norway BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key...

2014-03-06 13:13:25

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors. Published today in the journal Science Translational...

2014-03-05 23:30:46

Donations to Benefit Pediatric Cancer Research in Honor of Song’s Namesake Cary, NC (PRWEB) March 05, 2014 The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, is excited to announce that it will receive $100,000 from the sales of international superstar Taylor Swift’s single “Ronan,” whose proceeds benefit pediatric cancer research. Swift’s donation will add to the more than $14 million The V Foundation has already awarded...

2014-03-05 23:03:44

Project Impact aims to fundamentally change the way new pediatric cancer therapies are developed and tested, through public policy and a funded research program. Boston, MA (PRWEB) March 05, 2014 National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, today announced the launch of Project Impact: Driving Discovery to a Cure for Pediatric Brain Tumors, an integrated research and drug development program that seeks to confront the...

2014-03-05 10:44:37

By eliminating Mcl-1, radiation and chemotherapies could be more effective in treating the most common and deadly of all cancers Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer (NSCLC) makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer, which by far...

2014-03-03 16:25:26

$250,000 to support immuno-oncology learning resources WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is honored to announce a grant of $250,000 from Bristol-Myers Squibb for the development of educational materials on immuno-oncology. Progress in understanding lung cancer and treatment approaches has accelerated dramatically in the past several years after many slow decades. While no immunotherapeutic drugs are currently approved for lung cancer, this new area of...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related